CLINICAL_TRIALS
trial_result
· 2015-03-17
Clinical Trial Update: Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancer [Phase 1, Phase 2]
Summary
A safety study evaluating sorafenib with androgen deprivation and radiotherapy for prostate cancer was terminated with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Beth Israel Medical Center | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2015-03-17